Shine Technologies News Today

Blue Earth Therapeutics will leverage Shine's non-carrier added lutetium-177 chloride, Ilumira, in a new treatment for prostate cancer undergoing clinical trials

WARF Therapeutics is taking a unique-to-Wisconsin approach to anchoring an emerging medical industry within a 100-mile radius of the state Capitol. The benefits are potentially immense.

Wisconsin has a competitive advantage in fusion research, with the University of Wisconsin-Madisons Fusion Technology Institute producing 167 Ph.D. graduates in fusion engineering. Private investment in the fusion market is expected to grow as the world seeks clean energy options.

Former United States Speaker of the House and former vice presidential nominee Paul Ryan visited OU’s Norman campus on Wednesday, telling students to engage with their communities and protect democracy.

Scottsdale, Ariz., Feb. 27, 2024 (GLOBE NEWSWIRE) -- CISO Global (NASDAQCM: CISO), an industry leader as a managed cybersecurity and compliance provider,...

/PRNewswire/ -- SHINE Technologies, a global leader in nuclear fusion technology and radioisotope production, is proud to announce the appointment of three...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Wicked Stability team members reconvened at thePACKout to discuss new workstreams and next steps for testing and proving the project’s hypothesis.

/PRNewswire/ -- SHINE Technologies, an innovator in nuclear fusion technologies, and Curadh MTR Inc. (Curadh), specialists in molecularly targeted radiation...

SHINE Technologies has announced 59 of its employees in Janesville have been laid off.